Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
South Carolina measles outbreak grows by nearly 100, spreads to North Carolina and Ohio - 2Quandoo to shut restaurant booking platform by end of 2026
- 35 things for parents to know about changes to kids vaccine schedule
- 4EU health regulator urges immediate vaccinations amid early surge in flu cases
- 5Winter storm headed for Midwest to Northeast. Here's how much snow to expect.
- Man who grabbed Ariana Grande at 'Wicked: For Good' premiere also rushed Katy Perry onstage this year. Who is he and why is he doing this?
- Germany ready to assist Syria's reconstruction, says foreign minister
- Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- Dominating Capable Mastercard Utilization: Key Contemplations
- More Than 110 New Species Discovered In Deep Waters Off Australia
- Glen Powell will host 'Saturday Night Live' with Olivia Dean as musical guest: What to know ahead of their debut
- Underestimated Metropolitan Experience Urban communities On the planet
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Figure out How to Function Successfully with Your Auto Collision Legal advisor for the Best Result
